BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24163404)

  • 1. Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.
    Wang C; Xu CX; Bu Y; Bottum KM; Tischkau SA
    Carcinogenesis; 2014 Mar; 35(3):703-13. PubMed ID: 24163404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
    Siraj MA; Jacobs AT; Tan GT
    Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled receptor 30 mediates cell proliferation of goat mammary epithelial cells via MEK/ERK&PI3K/AKT signaling pathway.
    Zhao Y; Liu H; Fan M; Miao Y; Zhao X; Wei Q; Ma B
    Cell Cycle; 2022 Oct; 21(19):2027-2037. PubMed ID: 35659445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
    Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
    Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
    Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
    PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells.
    Srinivasan S; Koduru S; Kumar R; Venguswamy G; Kyprianou N; Damodaran C
    Int J Cancer; 2009 Aug; 125(4):961-7. PubMed ID: 19384950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
    Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
    Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
    Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
    J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphenol AF exerts estrogenic activity in MCF-7 cells through activation of Erk and PI3K/Akt signals via GPER signaling pathway.
    Lei B; Sun S; Zhang X; Feng C; Xu J; Wen Y; Huang Y; Wu M; Yu Y
    Chemosphere; 2019 Apr; 220():362-370. PubMed ID: 30590302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BC-N102 suppress breast cancer tumorigenesis by interfering with cell cycle regulatory proteins and hormonal signaling, and induction of time-course arrest of cell cycle at G1/G0 phase.
    Lawal B; Kuo YC; Wu ATH; Huang HS
    Int J Biol Sci; 2021; 17(12):3224-3238. PubMed ID: 34421361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 regulates breast cancer proliferation and survival.
    Rodriguez M; Potter DA
    Mol Cancer Res; 2013 Jul; 11(7):780-92. PubMed ID: 23576571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.